Skip to main navigation Skip to search Skip to main content

Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization

  • A. Saxena
  • , Checo J Rorie
  • , D. Dimitrova
  • , Y. Daniely
  • , J. A. Borowiec
  • New York University Cancer Institute
  • Gamida-Cell, Ltd.

Research output: Contribution to journalArticlepeer-review

77 Scopus citations

Abstract

Nucleolin is a c-Myc-induced gene product with defined roles in ribosomal RNA processing and the inhibition of chromosomal DNA replication following stress. Here we find that changes in nucleolin protein levels in unstressed cells cause parallel changes in the amount of p53 protein. Alterations in p53 levels arise from nucleolin binding to the p53 antagonist Hdm2, resulting in the inhibition of both p53 ubiquitination and Hdm2 auto-ubiquitination. Nucleolin does not alter p53 ubiquitination by human papillomavirus E6, indicating that the effect is specific for Hdm2. Although the inhibition of ligase activity would be expected to stabilize Hdm2, we instead find that nucleolin also reduces Hdm2 protein levels, demonstrating that nucleolin inhibits Hdm2 using multiple mechanisms. Increases in nucleolin levels in unstressed cells led to higher expression of p21cip1/waf1, a reduced rate of cellular proliferation, and an increase in apoptosis. Thus, nucleolin has a number of properties in common with the tumor suppressor ARF (alternate reading frame). We propose that nucleolin, like ARF, responds to hyperproliferative signals by upregulation of p53 through Hdm2 inhibition. © 2006 Nature Publishing Group. All rights reserved.
Original languageEnglish
Pages (from-to)7274-7288
Number of pages15
JournalOncogene
Volume25
Issue number55
DOIs
StatePublished - Nov 23 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ARF
  • Mdm2
  • Nucleolin
  • p53
  • Ubiquitination

Fingerprint

Dive into the research topics of 'Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization'. Together they form a unique fingerprint.

Cite this